Korro Bio, Inc.
Income Statement
| Line Item | FY2018 | FY2017 |
|---|---|---|
| Revenue | — | — |
| Cost of Revenue | — | — |
| Gross Profit | — | — |
| Gross Margin | — | — |
| Operating Expenses | ||
| Research & Development | $11.9M | $12.0M |
| SG&A Expense | $7.1M | $4.3M |
| Operating Income | $-18.9M | $-16.3M |
| Operating Margin | — | — |
| Interest Expense | — | — |
| Pretax Income | — | — |
| Income Tax Expense | — | — |
| Net Income | $-19.2M | $-20.2M |
| Net Margin | — | — |
| EPS (Basic) | $-0.35 | $-0.80 |
| EPS (Diluted) | $-0.35 | $-0.80 |
| Shares Outstanding (Basic) | 75.0M | — |
| Shares Outstanding (Diluted) | 75.0M | — |
| Dividends Per Share | — | — |